IP Library Granted Patent US 8,808,981
Granted Patent B2
US 8,808,981 · App. 14/115,691 · Granted Aug 19, 2014

Point-of care, medical condition screening kit

Inventors: Sean Mongale (Jacksonville, FL); Shishira Nagesh (Bangalore, IN); Ezra Taylor (Pike Road, AL); Mary O'Grady (Anchorage, AK); Thembi Mdluli (West Lafayette, IN); Peter Truskey (Durham, NC); Sherri Hall (Cary, IL); James Waring, III (Baltimore, MD); Britni Crocker (Long Valley, NJ); Harshard Sanghvi (Reisterstown, MD); Elaine Yang (Newark, DE); Soumyadipta Acharya (Baltimore, MD); Maxim Budyansky (Hartford, CT); Matthew Means (Baltimore, MD)
Assignee: Jhpiego Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,808,981
App. No.
14/115,691
Granted
Aug 19, 2014
Kind
B2
Abstract

A point-of-care, screening kit for use by a heath care worker to create custom test strips for screening the bodily fluids of an individual for various, medical conditions includes: (a) a plurality of reagents ( 12 ), (b) a substrate ( 18 ) configured to: i) receive one of the reagents and react with it so as to cause it to acquire a first characteristic color, and, ii) upon the addition of the individual's bodily fluid to the substrate, acquire, as a result of the formulation of each of the reagents, a second, dichotomous characteristic color when the individual has a specific one of the various, medical conditions. This kit also includes: (c) a plurality of containers ( 10 ) having indicia ( 26 ) that are reflective of the reagent within the container and which of the various medical conditions is being screened for with the use of the container and the characteristic first and second colors which are indicative of the individual having a screened for medical condition, and (d) one of the reagents being a protein reagent that includes appropriate quantities of: water, isopropyl alcohol, citric acid monohydrate, sodium citrate iribasic monohydrate, tetrabromophenol blue and tartrazine.

Claims (72)

1. A point-of-care screening kit ( 1 ) for use by heath care workers to make custom test strips to screen the bodily fluids of an individual for various, medical conditions, said kit comprising:

a reagent ( 12 ),

a substrate ( 18 ) having an outer surface ( 18 a ) that has a configuration adapted is configured to: a) receive said reagent ( 12 ) and react with said reagent so as to cause said substrate outer surface to acquire a first characteristic color that is indicative of one of said medical conditions for which said screening is being undertaken, and, b) upon the addition of a specified quantity of said bodily fluid of said individual to a portion of said substrate containing said reagent, acquire a second characteristic color that is indicative of said individual having said medical conditions for which said screening is being undertaken,

a container ( 10 ) having an outer surface ( 10 a ) that includes an orifice ( 10 b ), said container having a configuration adapted configured to receive and store a prescribed quantity of said reagent ( 12 ), and

a reagent-dispensing tip ( 14 ) that has a configuration adapted to dispense said reagent which is stored in said container.

2. The point-of-care screening kit as recited in claim 1 , wherein:

said container outer surface ( 10 a ) has indicia ( 26 ) that is indicative of one of said characteristic colors which are involved with said screening for one of said medical conditions.

3. The point-of-care screening kit as recited in claim 1 , further comprising:

a container closing means ( 16 ) which has a configuration adapted to cover said reagent-dispensing tip ( 14 ) of said container when said reagent-dispensing tip is not in use.

4. The point-of-care screening kit as recited in claim 2 , further comprising:

a container closing means ( 16 ) which has a configuration adapted to cover said reagent-dispensing tip ( 14 ) of said container when said reagent-dispensing tip is not in use.

5. The point-of-care screening kit as recited in claim 3 , wherein:

said container closing means ( 16 ) has indicia ( 26 ) that is indicative of one of said characteristic colors which are involved with said screening for one of said medical conditions.

6. The point-of-care screening kit as recited in claim 4 , wherein:

said container closing means ( 16 ) has indicia ( 26 ) that is indicative reflective of one of said characteristic colors which are involved with said screening for one of said medical conditions.

7. The point-of-care screening kit as recited in claim 1 , wherein:

said reagent ( 12 ) has a configuration adapted to yield a dichotomous color change on said substrate, and

said substrate is a filter paper having a configuration selected from the group consisting of a roll or pre-perforated strips, individual strips and individual sheets.

8. The point-of-care screening kit as recited in claim 7 , wherein:

said reagent ( 12 ) is a protein reagent that has a configuration adapted is configured to test for the presence of protein when said bodily fluid of said individual is urine, and wherein said protein reagent includes appropriate quantities of the following components: water, isopropyl alcohol, citric acid monohydrate, sodium citrate tribasic dihydrate, tetrabromophenol blue and tartrazine.

9. The point-of-care screening kit as recited in claim 8 , wherein:

said appropriate quantities of said protein reagent components are in the range of: water—5-10 mL, isopropyl alcohol—0-5 mL, citric acid monohydrate—1-1.5 g, sodium citrate tribasic dihydrate—0.22-0.65 g, tetrabromophenol blue—5-15 mg, and tartrazine—0-15 mg.

10. The point-of-care screening kit as recited in claim 1 , wherein:

said reagent ( 12 ) is a plurality of reagents selected from the group consisting of reagents used to screen for: (a) protein, (b) glucose, (c) nitrites, (d) leukocytes, (e) ketone bodies, (f) bilirubin, and (g) urobilinogen,

said container ( 10 ) is a plurality of containers, each of which has a configuration adapted to receive and store one of said plurality of reagents,

said reagent-dispensing tip ( 14 ) is a plurality reagent-dispensing tips, each of which has a configuration adapted to dispense a uniform, prescribed quantity of said reagent that is stored in said container with which said reagent-dispensing tip is associated, and

wherein each of said container outer surfaces ( 10 a ) has indicia ( 26 ) that is indicative of one of said characteristic colors which are involved with said screening for one of said medical conditions.

11. The point-of-care screening kit as recited in claim 10 , wherein:

each of said reagents ( 12 ) has a configuration adapted to yield a dichotomous color change on said substrate.

12. The point-of-care screening kit as recited in claim 1 , wherein:

said reagent ( 12 ) is a plurality of reagents, each of which has a configuration adapted to yield a dichotomous color change on said substrate,

said container ( 10 ) is a plurality of containers, each of which has a configuration adapted to receive and store one of said plurality of reagents,

said reagent-dispensing tip ( 14 ) is a plurality reagent-dispensing tips, each of which has a configuration adapted to dispense a uniform, prescribed quantity of said reagent that is stored in said container,

wherein each of said container outer surfaces ( 10 a ) has indicia ( 26 ) that is indicative of one of said characteristic colors which are involved with said screening for one of said medical conditions,

wherein one of said plurality of reagents is a protein reagent that has a configuration adapted to test for the presence of protein when said bodily fluid of said individual is urine, and

wherein said protein reagent includes appropriate quantities of the following components: water, isopropyl alcohol, citric acid monohydrate, sodium citrate tribasic monohydrate, tetrabromophenol blue, and tartrazine.

13. A method of providing a point-of-care screening kit for use by heath care workers to make custom test strips to screen the bodily fluids of an individual for various medical conditions, said method comprising the steps of:

providing a reagent ( 12 ),

providing a substrate ( 18 ) having an outer surface ( 18 a ) that has a configuration adapted to: a) receive said reagent and react with said reagent so as to cause said substrate outer surface to acquire a first characteristic color that is indicative of one of said medical conditions for which said screening is being undertaken, and, b) upon the addition of a specified quantity of said bodily fluid of said individual to a portion of said substrate containing said reagent, acquire a second characteristic color that is indicative of said individual having medical conditions for which said screening is being undertaken,

providing a container ( 10 ) having an outer surface ( 10 a ) that includes an orifice ( 10 b ), said container having a configuration adapted to receive and store a prescribed quantity of said reagent ( 12 ), and

providing a reagent-dispensing tip ( 14 ) that has a configuration adapted to dispense said reagent which is stored in said container.

14. The method of providing the point-of-care screening kit as recited in claim 13 , wherein:

said container outer surface ( 10 a ) has indicia ( 26 ) that is indicative of one of said characteristic colors which are involved with said screening for one of said medical conditions.

15. The method of providing the point-of-care screening kit as recited in claim 13 , further comprising:

providing a container closing means ( 16 ) which has a configuration adapted to cover said reagent-dispensing tip ( 14 ) of said container when said reagent-dispensing tip is not in use.

16. The method of providing the point-of-care screening kit as recited in claim 14 , further comprising:

providing a container closing means ( 16 ) which has a configuration adapted to cover said reagent-dispensing tip ( 14 ) of said container when said reagent-dispensing tip is not in use.

17. The method of providing the point-of-care screening kit as recited in claim 15 , wherein:

said container closing means ( 16 ) has indicia ( 26 ) that is indicative of one of said characteristic colors which are involved with said screening for one of said medical conditions.

18. The method of providing the point-of-care screening kit as recited in claim 16 , wherein:

said container closing means ( 16 ) has indicia ( 26 ) that is indicative of one of said characteristic colors which are involved with said screening for one of said medical conditions.

19. The method of providing the point-of-care screening kit as recited in claim 13 , wherein:

said reagent ( 12 ) has a configuration adapted to yield a dichotomous color change on said substrate, and

said substrate is a filter paper having a configuration chosen from the group pre-perforated strips, individual strips and individual sheets.

20. The method of providing the point-of-care screening kit as recited in claim 19 , wherein:

said reagent ( 12 ) is a protein reagent that has a configuration adapted is configured to test for the presence of protein when said bodily fluid of said individual is urine, and wherein said protein reagent includes appropriate quantities of the following components: water, isopropyl alcohol, citric acid monohydrate, sodium citrate tribasic dihydrate, tetrabromophenol blue and tartrazine.

21. The method of providing the point-of-care screening kit as recited in claim 20 , wherein:

said appropriate quantities of said protein reagent components are in the range of: water—5-10 mL, isopropyl alcohol—0-5 mL, citric acid monohydrate—1-1.5 g, sodium citrate tribasic dihydrate—0.22-0.65 g, tetrabromophenol blue—5-15 mg, and tartrazine—0-15 mg.

22. The method of providing the point-of-care screening kit as recited in claim 13 , wherein:

said reagent ( 12 ) is a plurality of reagents selected from the group consisting of reagents used to screen for: (a) protein, (b) glucose, (c) nitrites, (d) leukocytes, (e) ketone bodies, (f) bilirubin, and (g) urobilinogen,

said container ( 10 ) is a plurality of containers, each of which has a configuration adapted to receive and store one of said plurality of reagents,

said reagent-dispensing tip ( 14 ) is a plurality reagent-dispensing tips, each of which has a configuration adapted to dispense a uniform, prescribed quantity of said reagent that is stored in said container with which said reagent-dispensing tip is associated, and

wherein each of said container outer surfaces ( 10 a ) has indicia ( 26 ) that is indicative of one of said characteristic colors which are involved with said screening for one of said medical conditions.

23. The method of providing the point-of-care screening kit as recited in claim 22 , wherein:

each of said reagents ( 12 ) has a configuration adapted to yield a dichotomous color change on said substrate.

24. The method of providing the point-of-care screening kit as recited in claim 13 , wherein:

said reagent ( 12 ) is a plurality of reagents, each of which has a configuration adapted to yield a dichotomous color change on said substrate,

said container ( 10 ) is a plurality of containers, each of which has a configuration adapted to receive and store one of said plurality of reagents,

said reagent-dispensing tip ( 14 ) is a plurality reagent-dispensing tips, each of which has a configuration adapted to dispense a uniform, prescribed quantity of said reagent that is stored in said container,

wherein each of said container outer surfaces ( 10 a ) has indicia ( 26 ) that is indicative of one of said characteristic colors which are involved with said screening for one of said medical conditions,

wherein one of said plurality of reagents is a protein reagent that has a configuration adapted to test for the presence of protein when said bodily fluid of said individual is urine, and

wherein said protein reagent includes appropriate quantities of the following components: water, isopropyl alcohol, citric acid monohydrate, sodium citrate tribasic monohydrate, tetrabromophenol blue, and tartrazine.

Continuity (5)
Provisional Application 61483482 · May 6, 2011
Provisional Application 61563274 · Nov 23, 2011
Provisional Application 61563281 · Nov 23, 2011
Provisional Application 61563285 · Nov 23, 2011
Related Publication 20140093896A1 · Apr 3, 2014